Key Players and Innovative Start-Ups in Nutraceuticals: Emerging strategies in ingredients, pharma, food and drinks

Date: November 22, 2009
Pages: 163
Price:
US$ 4,795.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: KB91F22475BEN
Leaflet:

Download PDF Leaflet

Key Players and Innovative Start-Ups in Nutraceuticals: Emerging strategies in ingredients, pharma, food and drinks
Nutraceuticals are bioactive compounds with properties beneficial to health that are often concentrated extracts from fruits, herbs, seeds, specific lipids and vegetables. Nutraceuticals are often used to fortify food products, creating functional foods, or can be taken as supplements. Pharmaceuticals, on the other hand, are bioactive compounds intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Pharmaceuticals are most often new chemical entities.

Well known nutraceuticals include essential fatty acids such as omega-3 oils, probiotics, prebiotics, plant sterols, botanicals, superfruit extracts, carotenoid antioxidants and soy protein/isoflavones. Over the past few years, most of these nutraceutical ingredients have made good progress in the marketplace and are now available in a wide range of foods and drinks, as well as supplements. Some have also been developed as pharmaceuticals.

The consumer environment is driving growth in the nutraceuticals market. Over the past decade, consumers have become more concerned for their health and are increasingly inclined to self-medicate. Healthcare providers, too, are keen to shift some of the burden of healthcare costs to individuals and recognize that functional foods may provide alternatives to medications. These factors are reflected in the current market for ingredients in the health and nutrition sector, which was estimated to be worth US$4 billion in 2009.

Key Features of this report
  • Identify leading companies at the forefront of the nutraceuticals industry who will drive the market for a new generation of “value added” health products.
  • Provide case studies of these leading companies in the finished goods (foods and drinks), ingredients and other raw materials, or pharmaceutical sectors.
  • Analyze the key trends and issues confronting the different industry sectors at this time.
  • Review the backgrounds, discovery strategies and business models of new and innovative entrants to this marketplace.


Scope of this report
  • Identify the companies leading the field in the nutraceuticals industry from across a range of different market sectors
  • Review their key products and the ways in which these products are being marketed to consumers
  • Learn more about the increased efforts of these companies to establish the health benefits of their products in clinical trials
  • Identify innovative companies and discover the potential of their various approaches for discovery and marketing novel nutraceuticals

Key Market Issues
  • The food market is changing: Over the past decade, consumers have become more concerned for their health and are increasingly inclined to self-medicate. Healthcare providers, too, are keen to shift some of the burden of healthcare costs to individuals and recognize that functional foods may provide alternatives to medications. These factors are reflected in the current market for ingredients in the health and nutrition sector, which was estimated to be worth US$4billion in 2009.
  • Nutraceuticals and pharmaceuticals are related in that both are types of compound that demonstrate bioactive properties. Nutraceuticals are substances that are extracted from foods and are used either to fortify other food products in order to enhance their nutritional properties or are taken as dietary supplements in the form of pills, capsules of soft-gels. The clinical evidence behind a nutraceutical products varies widely; some have been tested with pharmaceutical rigor to demonstrate properties beneficial to health, while for other the evidence to support such claims is slim.

Key findings from this report
  • New food and drink regulations were introduced in Europe in 2006 and have been generating uncertainty and frustration throughout the industry. The European Food Safety Authority is processing more than 4,000 generic health claims, as well as health claims for emerging and proprietary science or disease risk reduction. The regulator has rejected a large number of the applications reviewed to date (September 2009) and has missed a number of deadlines, suggesting that the overall process may take much longer than expected.
  • FDA regulations are generally regarded as less stringent than those in the EU. Nevertheless, they come under criticism for not allowing companies to use in their product labeling relevant data generated in a clinical setting that links the food with a health benefit. Some of the smaller, innovative companies reviewed for this report are developing their business models with this fact in mind.

Key questions answered
  • Which companies are the market leaders in the nutraceuticals industry, as identified from a review of finished goods companies, raw materials manufacturers and pharmaceutical companies?
  • What are the key products of these companies and how do they exemplify the future direction of the nutraceutical industry?
  • How are the market leaders approaching the need for research to back their products with health claims that are understandable by the consumer?
Key Players and Innovative Start-ups in Nutraceuticals: Emerging strategies in ingredients, pharma, food and drinks
Executive summary
Defining nutraceuticals
Market leaders: food and drinks manufacturers
Market leaders: ingredients
Market leaders: pharmaceutical companies
Developing new ingredients: innovative start-up companies
Market drivers and trends

CHAPTER 1 DEFINING NUTRACEUTICALS

Summary
Introduction
Defining nutraceuticals
Examples of nutraceuticals
Omega-3 oils
Probiotics
Prebiotics
Plant stanols and sterols
Superfruits and antioxidants
The nutraceuticals market
Report outline

CHAPTER 2 MARKET LEADERS: FOOD AND DRINKS COMPANIES

Summary
Introduction
Market Leaders: Case studies
Case study: Nestl?
Case study: Unilever
Case study: Groupe Danone
Case study: PepsiCo
Case study: Coca-Cola
Conclusions

CHAPTER 3 MARKET LEADERS: INGREDIENTS

Summary
Introduction
Companies with diverse nutraceutical portfolios
Case study: DSM Nutritionals
Case study: Cognis
Case study: Cargill Inc
Case study: Ajinomoto
Case study: Kerry Group
Case study: Glanbia Foods
Probiotics
Case study: Chr. Hansen
Case study: Danisco
Prebiotics
Case study: BENEO
Fats and oils
Case study: Ocean Nutrition Canada
Agriculture
Case study: Dow AgroSciences
Case study: Monsanto
Case study: DuPont
Conclusions
CHAPTER 4 Market Leaders: Pharmaceutical companies
Summary
Introduction
Market leaders: Case studies
Case Study: Abbott Nutrition
Case study: Bayer Consumer Care
Case study: Pfizer
Case study: GSK Consumer Healthcare
Case study: McNeil Nutritionals
Case study: Mead Johnson Nutritionals
Discussion

CHAPTER 5 DEVELOPING NEW INGREDIENTS: INNOVATIVE START-UP COMPANIES

Summary
Introduction
Case study: Advana Science
Case study: WellGen Inc
Case study: InterMed Discovery
Case study: Provexis
Case study: Clasado Ltd
Case study: Cambridge Theranostics Ltd
Case Study: HerbalScience Group
Business models
Conclusions

CHAPTER 6 MARKET DRIVERS AND TRENDS

Summary
Introduction
Regulatory considerations
Japan
United States
Europe
Intellectual property
Development costs
Opportunities in the nutraceuticals market
Opportunities for medical foods
International emerging markets
The science driving the future foods market
Nutrigenomics and nutrigenetics
Epigenetics
Nanotechnology
Conclusions

CHAPTER 7 APPENDIX

Primary research methodology
Acknowledgments
Glossary
Index
Bibliography
Endnotes

LIST OF FIGURES

Figure 1.1: Different types of medical food and their uses
Figure 1.2: The health and nutrition sector
Figure 1.3: Key US consumer health concerns, 2009
Figure 1.4: The role of food and pharmaceuticals in the healthcare continuum
Figure 1.5: End products for nutraceutical ingredients
Figure 2.1: Danone’s sales figures by business line and sales region (2008)
Figure 3.1: Technologies for nutraceutical product development at Kerry Group
Figure 3.2: Defining Danisco’s Bioactives and Enabler ingredients
Figure 5.1: InterMed Discovery’s active ingredient pipeline
Figure 5.2: A comparison of research paradigms in the pharmaceutical and nutraceutical industries
Figure 5.3: Examples of business models adopted by innovative nutraceutical companies
Figure 6.1: Opportunities and threats for the nutraceuticals industry
Figure 6.2: Types of EFSA health claims
Figure 6.3: Key attributes for product success
Figure 6.4: Opportunities for medical foods
Figure 6.5: Growth in the number of potential consumers from developing and emerging countries: 2008-2018

LIST OF TABLES

Table 1.1: Examples of nutraceuticals
Table 1.2: Omega-3 and Omega-6 fatty acids and their dietary sources
Table 1.3: Examples of common antioxidants present in food
Table 2.1: Leading food companies: revenues and product focus
Table 2.2: Nestl? sales by product area (CHFm), 2008
Table 2.3: Nestl?’s Branded Active Benefits
Table 2.4: Examples of brands from Nestl? Nutrition
Table 2.5: Functional ingredients included in Danone’s dairy products
Table 3.6: Market leaders: Ingredients
Table 3.7: Nutraceutical or personalized nutrition companies participated in by DSM Venturing
Table 3.8: Examples of ingredients from Danisco
Table 4.1: Market Leaders: Pharma
Table 4.2: Leading nutraceutical products from Abbott Nutrition
Table 4.3: Leading nutraceutical products from Bayer Consumer Care
Table 4.4: Leading nutritional products from Pfizer
Table 5.1: Innovative companies and start-ups in the nutraceutical sector
Table 5.2: Examples of innovative companies exploring novel manufacturing methods
Table 5.3: Products or projects in development at Provexis
Table 6.1: Health claims meeting significant scientific agreement
Skip to top


Ask Your Question

Key Players and Innovative Start-Ups in Nutraceuticals: Emerging strategies in ingredients, pharma, food and drinks
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: